首页> 美国卫生研究院文献>The British Journal of Ophthalmology >Risk factors for proliferative vitreoretinopathy after primary vitrectomy: a prospective study
【2h】

Risk factors for proliferative vitreoretinopathy after primary vitrectomy: a prospective study

机译:玻璃体切除术后增生性玻璃体视网膜病变的危险因素:一项前瞻性研究

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。
获取外文期刊封面目录资料

摘要

AIM—To assess clinical variables and vitreous protein as risk factors for the development of postoperative proliferative vitreoretinopathy (PVR).
METHODS—A prospective study was conducted on 140 patients with a rhegmatogenous retinal detachment in whom a primary vitrectomy was performed. 12 clinical variables were recorded and vitreous samples obtained for measurement of protein concentration. Univariate and multivariate logistic regression analysis was used to determine the risk factors for PVR.
RESULTS—Complete data were available for 136 of 140 patients. 40 of the 136 patients (29.4%) developed postoperative PVR. Univariate regression revealed that significant (p<0.05) risk factors included aphakia, presence of preoperative PVR, size of detachment, the use of silicone oil, and high vitreous protein level. Multivariate regression analysis revealed only aphakia (odds ratio 2.72), the presence of preoperative PVR (odds ratio 3.01), and high vitreous protein concentration (odds ratio 1.11) to be significant (p<0.05) independent, predictive risk factors for the development of PVR.
CONCLUSIONS—This study has shown that the significant risk factors for PVR are preoperative PVR, aphakia, and high vitreous protein levels. Two models (clinical factors only and clinical factors and vitreous protein) were constructed to predict the probability of developing postoperative PVR and may be used to identify those at risk for possible intravitreal pharmacological treatment.

机译:目的-评估临床变量和玻璃体蛋白作为术后增生性玻璃体视网膜病变(PVR)发生的危险因素。
方法-对140例行原发性玻璃体切除术的视网膜源性视网膜脱离的患者进行了一项前瞻性研究。记录12个临床变量并获得玻璃体样品以测量蛋白质浓度。单因素和多因素logistic回归分析用于确定PVR的危险因素。
结果-140例患者中有136例的完整数据可用。 136例患者中有40例(29.4%)发生了术后PVR。单因素回归显示,重要的(p <0.05)危险因素包括无晶状体,术前PVR的存在,脱离的大小,硅油的使用以及玻璃体蛋白水平高。多元回归分析显示,仅无晶状体(奇数比为2.72),术前PVR(奇数比为3.01)和高玻璃体蛋白浓度(奇数比为1.11)的存在是显着(p <0.05)独立,可预测的发展性心绞痛危险因素PVR。结论—这项研究表明PVR的重要危险因素是术前PVR,无晶状体和玻璃体蛋白水平高。构建了两种模型(仅临床因素以及临床因素和玻璃体蛋白)来预测术后PVR的发生率,并可用于识别那些可能进行玻璃体内药理治疗的风险的人。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号